Neutral impactIPO
ICICI Prudential Nifty Pharma ETF: NFO dates, minimum investment and key details
CNBC TV18 1 hr ago·9 Oct 2026, 10:08 am
ICICI Prudential Nifty Pharma ETF is a new exchange-traded fund (ETF) that will track the performance of the Nifty Pharma Index. The fund is currently open for New Fund Offer (NFO), allowing investors to subscribe to units at a fixed price. This product is designed to give retail investors a convenient way to gain exposure to a basket of leading pharmaceutical companies in India.
For investors, this launch offers a cost-effective method to diversify their portfolio within the healthcare sector. Since it is an ETF, it is traded on the stock exchange like a regular share, providing liquidity and transparency. The fund aims to mirror the index's returns, making it a passive investment option for those looking to bet on the long-term growth of Indian pharma stocks.
Investors should pay attention to the expense ratio, which determines the fund's management costs. It is also important to monitor the fund's performance against the Nifty Pharma Index to ensure it is tracking effectively. As the NFO period concludes, the units will be listed on the exchange, and trading will begin at the prevailing market price.
Excerpt from CNBC TV18
Published On Oct 9, 2026 | 15:38 IST Last Updated On Oct 9, 2026 | 15:40 IST ICICI Prudential Mutual Fund is launching the Nifty Pharma ETF NFO on October 12, closing October 19. The open-ended fund tracks the Nifty Pharma Index, offering exposure to pharmaceutical stocks with a minimum investment of ₹1,000. ICICI…Read the original at CNBC TV18
Key takeaways
- Category: IPO.
Why it matters
A routine update. Use the price and stock snapshot to gauge how the market is responding.
